PRDX1 and colorectal cancer: These results indicate that PRDX1 is the dominant target protein of Celastrol and compound 19-048 in colorectal cancer cells, and the inhibition of PRDX1 leads to elevated intracellular ROS as well as increased cell cycle arrest and apoptosis.